Detailed View
ETON - Eton Pharmaceuticals, Inc.
Latest filing: 2026-06-30 | Reporting: gaap
Market Cap
1,631,525,504
Adj EBIT (TTM)
21,511,000
Enterprise Value
1,632,583,504
Last Price
57.08
Earnings Yield
1.32%
Return on Capital
86.03%
Capital
25,005,000
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-06-30 | 10-Q | 2026 | 37,589,000 | 12,794,000 |
| 2026-03-31 | 10-Q | 2026 | 24,266,000 | 2,414,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 21,281,000 | 2,464,000 |
| 2025-09-30 | 10-Q | 2025 | 22,459,000 | -1,363,000 |
| 2025-06-30 | 10-Q | 2025 | 18,928,000 | -1,475,000 |
| 2025-03-31 | 10-Q | 2025 | 17,282,000 | -470,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 11,647,000 | 629,000 |
| 2024-09-30 | 10-Q | 2024 | 10,324,000 | 509,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.